BusinessInspyr Broadens Intellectual Property Portfolio with New Patent Issued on Methods for Producing Cancer CompoundsBy Nasdaq OMXOct 20, 2016, 11:01 AM UTC
BusinessInspyr Therapeutics Appoints Richard Buller, M.D., Ph.D. to Board of DirectorsBy Nasdaq OMXOct 13, 2016, 11:00 AM UTC
BusinessInspyr Therapeutics Appoints Claire Thom, Pharm.D. to Board of DirectorsBy Nasdaq OMXOct 12, 2016, 11:00 AM UTC
BusinessInspyr Therapeutics Strengthens Clinical Development Capabilities with Appointment of Michael Elliott as Vice President of Clinical OperationsBy Nasdaq OMXOct 11, 2016, 11:00 AM UTC
